Astellas Pharma Inc. (ALPMY)

Astellas Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 5, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	27,849	17,292	19,482	25,437	28,985	28,585
Market Cap Growth	62.14%	-11.24%	-23.41%	-12.24%	1.40%	-0.95%
Enterprise Value	30,860	22,203	23,576	22,597	26,106	25,824
Last Close Price	15.74	9.66	10.75	14.20	15.58	15.44
PE Ratio	13.52	51.03	172.88	34.26	28.37	26.22
PS Ratio	2.12	1.35	1.84	2.23	2.72	2.53
PB Ratio	2.47	1.71	1.85	2.24	2.41	2.28
P/TBV Ratio	15.88	-	-	5.48	6.59	7.02
P/FCF Ratio	10.73	16.44	21.92	11.61	15.53	11.48
P/OCF Ratio	9.54	13.31	17.09	10.32	13.67	10.30
EV/Sales Ratio	2.35	1.74	2.22	1.98	2.45	2.29
EV/EBITDA Ratio	7.98	7.19	12.63	8.90	10.64	8.83
EV/EBIT Ratio	11.67	12.62	28.62	12.97	14.53	11.38
EV/FCF Ratio	11.89	21.11	26.53	10.31	13.98	10.37
Debt / Equity Ratio	0.41	0.62	0.63	0.14	0.15	0.20
Debt / EBITDA Ratio	1.19	2.03	3.57	0.61	0.72	0.86
Debt / FCF Ratio	1.78	5.95	7.50	0.70	0.94	1.01
Asset Turnover	0.58	0.55	0.53	0.63	0.56	0.54
Inventory Turnover	1.27	1.28	1.38	1.76	1.60	1.56
Quick Ratio	0.79	0.79	0.69	1.13	1.05	1.15
Current Ratio	1.09	1.13	0.93	1.45	1.34	1.47
Return on Equity (ROE)	19.81%	3.26%	1.10%	6.65%	8.72%	9.01%
Return on Assets (ROA)	7.38%	4.77%	2.58%	6.05%	5.92%	6.83%
Return on Invested Capital (ROIC)	16.07%	11.63%	4.72%	12.83%	12.80%	15.28%
Return on Capital Employed (ROCE)	18.30%	11.60%	5.50%	13.40%	13.30%	14.90%
Earnings Yield	7.40%	1.96%	0.58%	2.92%	3.52%	3.81%
FCF Yield	9.32%	6.08%	4.56%	8.62%	6.44%	8.71%
Dividend Yield	3.25%	5.12%	4.30%	3.18%	2.64%	2.46%
Payout Ratio	44.71%	254.19%	684.38%	101.66%	68.69%	63.15%
Buyback Yield / Dilution	-0.64%	0.14%	1.39%	1.38%	0.41%	1.03%
Total Shareholder Return	2.69%	5.25%	5.70%	4.56%	3.05%	3.49%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.